BDSX — BIODESIX INC
—
Nasdaq ·
Health Care ·
Health Care Providers & Services ·
CIK 1439725 ·
Last close
$8.88
Market Cap
$98.47M
52W High
$31.97
52W Low
$5.26
ADV30
217,486
Next earnings
2026-11-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 24,041,000 | 19,381,000 | -6,112,000 | -8,032,000 | 93,944,000 | 28,409,000 | 85,269,000 |
| Jun 2026 | 26,861,000 | 22,041,000 | -5,376,000 | -7,273,000 | 95,326,000 | 29,996,000 | 86,182,000 |
| Mar 2026 | 25,555,000 | 21,350,000 | -6,196,000 | -7,793,000 | 94,637,000 | 25,572,000 | 85,505,000 |
| Dec 2025 | 28,755,000 | 23,876,000 | -1,966,000 | -3,980,000 | 87,476,000 | 18,987,000 | 89,941,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-19,831,000
Investing CF
$-569,000
Financing CF
$29,668,000
CapEx
$-569,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-3.17
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$-512,828,000
Inventory
—
Receivables
$9,113,000
ST Investments
—
EBIT TTM
$-19,670,000
Pretax Income TTM
$-27,762,000
Interest Exp TTM
$8,092,000
Analysts
6
Yahoo Snapshot (yfinance, live)
Total Revenue
$105,212,000
EBITDA
$-14,081,000
Free Cash Flow
$-10,199,750
Enterprise Value
$138,616,000
Total Cash
$28,409,000
Total Debt
$72,440,000
Shares Out
11,088,511
Trailing EPS
$-2.69
Book Value
$0.79
ROE
-778.9%
ROA
-13.4%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 88,499,000 | -27,766,000 | -35,265,000 | 87,476,000 | 89,941,000 | -2,465,000 | -23,271,000 |
| Dec 2024 | 71,323,000 | -34,260,000 | -42,931,000 | 97,244,000 | 76,368,000 | 20,876,000 | -48,649,000 |
| Dec 2023 | 49,087,000 | -41,298,000 | -52,146,000 | 99,096,000 | 94,516,000 | 4,580,000 | -22,870,000 |
| Dec 2022 | 38,212,000 | -50,506,000 | -65,447,000 | 92,906,000 | 72,300,000 | 20,606,000 | -44,972,000 |
TTM Snapshot
Revenues TTM
$102,939,000
NetIncome TTM
$-27,762,000
OpCashFlow TTM
—
Assets (Latest)
$95,326,000
Forward EPS
$-0.22
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| XGN | EXAGEN INC. | $95.93M | $3.76 | — |
| PARK | Park Dental Partners, Inc. | $107.16M | $19.36 | — |
| BNR | Burning Rock Biotech Ltd | $110.17M | $12.50 | — |
| LFMD | LifeMD, Inc. | $86.76M | $1.79 | — |
| SERA | SERA PROGNOSTICS, INC. | $77.60M | $2.00 | — |
News headlines (Yahoo Finance, 1h cache)
Biodesix (BDSX) Stock Fair Value Moves Lower After Q3 Miss And Guidance Cut
2026-11-17 01:06 · Yahoo
Biodesix to Showcase MRD Strategy at the Association for Molecular Pathology (AMP) 2026 Annual Meeting
2026-11-09 11:00 · Yahoo
Biodesix (BDSX) Q3 2026 Earnings Call Transcript
2026-11-06 15:31 · Yahoo
Champions Oncology vs. Biodesix: Which Oncology Stock Is a Better Buy?
2026-11-06 15:16 · Yahoo
Biodesix Inc (BDSX) (Q3 2026) Earnings Call Highlights: Revenue Growth Offset by Sales Force ...
2026-11-06 05:27 · Yahoo
What Biodesix (BDSX) Said on Its Q3 Earnings Call
2026-11-05 23:14 · Yahoo
Biodesix, Inc. (BDSX) Reports Q3 Loss, Lags Revenue Estimates
2026-11-05 21:45 · Yahoo
Biodesix Announces Third Quarter 2026 Results and Highlights
2026-11-05 21:01 · Yahoo
Biodesix to Participate in Upcoming Investor Conferences
2026-11-04 11:00 · Yahoo
All You Need to Know About Biodesix (BDSX) Rating Upgrade to Buy
2026-10-29 15:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.